Jesus Berdeja
MD
Director, Myeloma Research
👥Biography 个人简介
Jesus Berdeja has been a central investigator in the CARTITUDE clinical trial program evaluating ciltacabtagene autoleucel (cilta-cel) for multiple myeloma. His work demonstrated unprecedented response rates and deep remissions with cilta-cel in heavily pretreated patients. He has been instrumental in advancing BCMA CAR-T therapy to earlier treatment lines.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Jesus Berdeja 的研究动态
Follow Jesus Berdeja's research updates
留下邮箱，当我们发布与 Jesus Berdeja（Sarah Cannon Research Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment